EUVIMEDEUVIMED entdecken
Crossref

Mitochondria‐targeting Bimetallic Cluster Nanozymes Alleviate Neuropathic Pain Through Scavenging ROS and Reducing Inflammation

Xiaolei Cheng, Tianjiao Xia, Min Han, Minhui Xu, Weining Yuan, Ziqi Wei, Wei Jiang iD, Hao Tang, Qian Bai, Xiaoping Gu

Advanced Healthcare Materials · 2025-03 · 14 (8)

DOI: 10.1002/adhm.202401607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.01.2025. Verfasst von Xiaolei Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Drum Tower Hospital of Medical School of Nanjing University, Nanjing, Jiangsu, 210008, China. Hauptthemen laut MEDLINE: Neuralgia, Mitochondria, Reactive Oxygen Species, Inflammation. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Jiangsu Funding Program for Excellent Postdoctoral Talent.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain is a significant public health concern. Inflammatory mediators and reactive oxygen species (ROS) are recognized as primary contributors to pain perception. In this study, a mitochondria‐targeted modification of bimetallic cluster nanozyme (TPP‐Au‐Ru) is developed. This TPP‐Au‐Ru nanozyme exhibits a high affinity for the mitochondrial matrix, effectively scavenging ROS and attenuating inflammatory mediators in both in vitro and in vivo settings. Additionally, the nanozyme inhibits the activation of the MAPK and NF‐κB signaling cascades and protect mitochondrial function. Furthermore, a therapeutic dose of the TPP‐Au‐Ru nanozyme is able to alleviate nociceptive symptoms for up to 36 h with minimal biological toxicity. Therefore, the sustained mitochondrial delivery of TPP‐Au‐Ru nanozyme provides an effective and long‐lasting approach to neuropathic pain. This innovative approach shows promise for the development of more efficient therapeutic interventions, potentially revolutionizing the management of neuropathic pain and enhancing the quality of life for affected individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaMitochondriaReactive Oxygen SpeciesInflammationMetal NanoparticlesAnimalsMiceGoldMaleHumansRutheniumNF-kappa BRats, Sprague-Dawley

Stichwörter der Autor:innen

antioxidantmitochondria targetingnanozymeneuropathic pain

Substanzen

Reactive Oxygen SpeciesGoldRutheniumNF-kappa B

Autor:innen und Institutionen

  • Department of Anesthesiology, Affiliated Drum Tower Hospital of Medical School of Nanjing University, Nanjing, Jiangsu, 210008, China.
  • Zhengzhou Key Laboratory of Cardiovascular Aging, National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascul…
  • Medical School, Nanjing University, Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, 210093, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, 250014, P.R.China.
  • Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China.
  • The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.

ORCID-Profile: Wei Jiang

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Jiangsu Funding Program for Excellent Postdoctoral Talent

Zitieren

APA

Cheng, X., Xia, T., Han, M., Xu, M., Yuan, W., Wei, Z., Jiang, W., Tang, H., Bai, Q., & Gu, X. (2025). Mitochondria‐targeting Bimetallic Cluster Nanozymes Alleviate Neuropathic Pain Through Scavenging ROS and Reducing Inflammation. Advanced Healthcare Materials, 14(8). https://doi.org/10.1002/adhm.202401607

Vancouver

Cheng X, Xia T, Han M, Xu M, Yuan W, Wei Z, et al. Mitochondria‐targeting Bimetallic Cluster Nanozymes Alleviate Neuropathic Pain Through Scavenging ROS and Reducing Inflammation. Advanced Healthcare Materials. 2025;14(8). doi:10.1002/adhm.202401607

BibTeX
@article{Cheng2025,
  author = {Cheng, Xiaolei and Xia, Tianjiao and Han, Min and Xu, Minhui and Yuan, Weining and Wei, Ziqi and Jiang, Wei and Tang, Hao and Bai, Qian and Gu, Xiaoping},
  title = {Mitochondria‐targeting Bimetallic Cluster Nanozymes Alleviate Neuropathic Pain Through Scavenging ROS and Reducing Inflammation},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {8},
  doi = {10.1002/adhm.202401607}
}
Kostenlos starten →